Pain Assessment and Quality of Life in Back Pain Patients: Role of Milnacipran

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Back Pain
Interventions
DRUG

Savella

"The patients will be titrated to the maintenance dose of 50 mg BID over a 7-day period, and will be on the medication for 10 weeks.~12.5 mg QD on day 1 12.5 mg BID on days 2 and 3 25 mg BID on days 4, 5, 6, and 7 50 mg BID beginning day 8"

Trial Locations (1)

02467

Brigham and Women's Hospital Pain Trials Center, Chestnut Hill

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Brigham and Women's Hospital

OTHER